UroGen Pharma Historical PE Ratio image   This URGN PE ratio history page last updated 11/19/2021
UroGen Pharma Historical PE Ratio Chart
Data adjusted for URGN split history

PeriodPriceGAAPAnnualizedPE
Q3 2021
11/15/2021
14.74-1.35-5.40NA
Q2 2021
8/4/2021
15.30-1.17-4.68NA
Q1 2021
5/13/2021
15.38-1.17-4.68NA
Q4 2020
3/18/2021
18.05-1.38-5.52NA
Q3 2020
11/9/2020
24.89-1.31-5.24NA
Q2 2020
8/10/2020
26.42-1.44-5.76NA
Q1 2020
5/7/2020
23.61-1.79-7.16NA
Q4 2019
3/2/2020
28.01-1.86-7.44NA
Q3 2019
11/12/2019
27.51-1.06-4.24NA
Q2 2019
8/9/2019
32.08-1.08-4.32NA
Q1 2019
5/9/2019
38.21-1.11-4.44NA
Q4 2018
2/28/2019
38.48-1.46-5.84NA
Q3 2018
11/12/2018
45.70-1.28-5.12NA
Q2 2018
8/14/2018
44.56-1.14-4.56NA
Q1 2018
5/15/2018
60.14-0.88-3.52NA
Q4 2017
3/15/2018
56.38-0.74-2.96NA
Q3 2017
11/14/2017
42.18-0.02-0.08NA
Q2 2017
8/14/2017
18.42-0.70-2.80NA
UroGen Pharma PE History Chart
PeriodPriceGAAPTTMPE
Q3 2021
11/15/2021
14.74-1.35-5.07NA
Q2 2021
8/4/2021
15.30-1.17-5.03NA
Q1 2021
5/13/2021
15.38-1.17-5.30NA
Q4 2020
3/18/2021
18.05-1.38-5.92NA
Q3 2020
11/9/2020
24.89-1.31-6.40NA
Q2 2020
8/10/2020
26.42-1.44-6.15NA
Q1 2020
5/7/2020
23.61-1.79-5.79NA
Q4 2019
3/2/2020
28.01-1.86-5.11NA
Q3 2019
11/12/2019
27.51-1.06-4.71NA
Q2 2019
8/9/2019
32.08-1.08-4.93NA
Q1 2019
5/9/2019
38.21-1.11-4.99NA
Q4 2018
2/28/2019
38.48-1.46-4.76NA
Q3 2018
11/12/2018
45.70-1.28-4.04NA
Q2 2018
8/14/2018
44.56-1.14-2.78NA
Q1 2018
5/15/2018
60.14-0.88-2.34NA
Q4 2017
3/15/2018
56.38-0.74NANA
Q3 2017
11/14/2017
42.18-0.02NANA
Q2 2017
8/14/2017
18.42-0.70NANA
How should the URGN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like UroGen Pharma. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this URGN Historical PE Ratio page.

What is the average historical PE for URGN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The URGN historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for URGN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The URGN historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the UroGen Pharma Historical PE Ratio information for UroGen Pharma' stock. The average URGN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average URGN historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this URGN historical PE result, against the recent PE: when this page was posted on 11/18/2021, the most recent closing price for URGN had been 12.52, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on URGN or any other given stock, valuation analysis for URGN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate UroGen Pharma PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for URGN. Thanks for visiting, and the next time you need to research URGN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.
 

UroGen Pharma Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.